All posts
Voice AI
Hana Health
September 11, 2026

What Does the Evidence Actually Say About Voice AI for Patient Follow-Up?

I spent eighteen months building a mental health app for people with bipolar disorder. It was beautiful. Mood tracking, sleep logs, a crisis plan you could tap through at three in the morning when everything felt like it was ending. We shipped it. We watched fifteen percent of patients open it in a given week.

Fifteen.

Then we stopped asking people to download anything and just called them instead. An AI made the calls. Same patients, same clinical goals, no icon on a home screen. Weekly engagement went to eighty-five percent, and I sat there staring at the dashboard feeling something between vindication and embarrassment, because I'd spent a year and a half solving the wrong problem with the wrong tool while the answer was sitting in my pocket the entire time.

That gap is why HANA exists. But I read something recently that made me sit with a harder question, and I want to be straight with you about it.

Is there real evidence that voice AI improves patient engagement?

Less than the marketing suggests. Deepgram's review of the published evidence found vendor-reported appointment lift claims ranging from twenty-one to forty-seven percent, and almost every one of them traces back to a vendor case study with a short measurement window, no control group, and no peer review. Zero randomized trials of AI voice agents for scheduling. That's the state of the field in 2026.

Look, I run one of these companies. It would be easy for me to skip past that. I'm not going to, because the industry grading its own homework is exactly how we end up with another decade of healthcare software nobody trusts.

Why do patients answer a phone call but ignore an app?

Because a call asks nothing of them. That's it. That's the whole mechanism.

I crossed the Australian desert with a circus once (feels like another lifetime, honestly) and the thing I remember most is which acts drew crowds. Not the aerial silk. Not the technically hardest thing anyone was doing. Fire chains. Somebody spinning fire in a dirt car park, because you could stand there with a beer and get it instantly.

An app is aerial silk. It's gorgeous and it demands that the patient download, register, remember, and return. A phone call is fire chains. It arrives. It asks one question. It's over in four minutes. We've documented what that looks like across our deployed clinical use cases, and the pattern holds regardless of specialty.

Does more patient monitoring actually reduce readmissions?

Not automatically, and this is where the field keeps embarrassing itself. The ACCOMPLISH randomized trial published in JAMA Network Open put 1,286 post-discharge sepsis and respiratory infection patients through four different remote monitoring strategies. None of them increased days at home. None reduced ninety-day readmission. In patients over sixty-five, monitoring was associated with fewer days at home than usual care.

Read that again. More surveillance, worse outcome, in the population everyone assumes benefits most.

The lesson isn't that follow-up is useless. It's that detecting a problem and solving a problem are different jobs, and an alert that routes nowhere is just anxiety with a timestamp.

What should a clinic measure instead of vendor claims?

Three things, and none of them are the number on the landing page.

Contact rate: what percentage of your target patients did you actually reach, not attempt. Resolution rate: of those reached, how many left the conversation with a booked appointment, an answered question, or a documented escalation. And cost per resolved contact, which is the only number your CFO will care about in six months. We publish our outcome methodology in our research rather than asking anyone to take a number on faith, and our pricing is built around resolved contacts for exactly this reason.

If a vendor can't give you those three, you're buying a story.

How do you deploy voice AI without becoming another unproven claim?

Run it as a comparison, not a launch. Pick one cohort. Keep your existing manual process running on a matched cohort beside it. Measure for ninety days before you decide anything.

It's slower. It's also the only version of this that survives contact with a quality committee. Our deployment documentation is written around that shape, because the clinics that ran a real comparison are the ones still running us two years later, and the ones that skipped it churned by month four.

Key Takeaways

The honest summary is that voice AI for patient follow-up has strong operational evidence and thin clinical evidence, and anyone telling you otherwise is selling. Engagement gains are real and large, and I'll defend the eighty-five percent number all day because we've measured it across more than a million interactions in five countries with zero critical adverse events. What's not established is the causal chain from engagement to hard clinical outcomes like readmission, and the ACCOMPLISH data should make everyone humble about assuming it.

So measure your own clinic. Compare against your own baseline. Treat every vendor claim, including mine, as a hypothesis until your data says otherwise. That's not cynicism. That's just how you end up with something that works.

FAQ

Does AI voice follow-up work better than text messaging?

For engagement depth, yes. Text gets acknowledgement, voice gets information. A patient will reply "ok" to a text but will tell a voice agent that they stopped taking the medication because it made them nauseous, which is the clinically useful thing.

Is voice AI patient follow-up HIPAA compliant?

It can be, but compliance lives in the whole stack, not the top layer. You need signed BAAs across every vendor touching audio, including the speech and model providers. Self-hosted deployments avoid most of this problem because the data never leaves your infrastructure.

How long before a clinic sees return on voice AI follow-up?

Most of our deployments show measurable recovered revenue inside sixty to ninety days, driven by rebooked no-shows and closed care gaps rather than headcount reduction. If you want to walk through what that would look like for your patient volume, grab a slot on my calendar and bring your actual numbers.